Comparative study on efficacy and safety of Rosuvastatin v/s Atorvastatin in patients with metabolic syndrome- a prospective observational study

Abstract

Background Metabolic Syndrome is a constellation of cardio metabolic abnormalities such as central obesity, dyslipidemia, hyperglycemia, hypertension, proinflammatory and prothrombotic state. Dyslipidemia is one of the important components of this syndrome and also important risk factor for cardiovascular disease. Statins are used as first line drugs for dyslipidemia but right now several drugs are available in Indian market and it is difficult for medical practitioners to select a suitable one among them. This is a study to evaluate the efficacy and safety of most commonly used atorvastatin with rosuvastatin in patients with metabolic syndrome. Objectives To compare the efficacy and safety of Rosuvastatin and Atorvastatin in patients with metabolic syndrome. Methods A total of 60 subjects diagnosed with Metabolic syndrome were included in the study. They were randomized into two groups, the first group received, Rosuvastatin 10mg and second group received Atorvastatin 10 mg for 6 weeks. Lipid profile was evaluated for efficacy; liver function tests (LFT) and serum creatine for safety. Adverse effects were evaluated based on symptomatology and laboratory parameters. Results Both the groups showed significant improvement in lipid profile, seen by reduction in LDL, Triglycerides, total cholesterol and increase in HDL levels compared to baseline values (p<0.001). Intergroup comparison showed that 10mg of Rosuvastatin was better in providing a favourable lipid profile compared to 10mg of Atorvastatin. Changes in LFT and serum creatine were not significant statistically both within and between the groups. Conclusion Rosuvastatin was found to be better than atorvastatin in providing a favourable lipid profile for patients with metabolic syndrome and both the drugs were well tolerated and safe.

Authors and Affiliations

Dr Sushma H K

Keywords

Related Articles

Pharmacovigilance - knowledge, attitude and practice among medical students in a teaching hospital of southern India

Background Drugs although used in the prevention and curing of diseases, are sometimes associated with undesirable adverse drug reactions (ADR). Spontaneous reporting of ADRs has remained the cornerstone and major sourc...

Antidepressant activity of ethanolic extract of neptunia natans on swiss albino mice

The aim of the study is to study the phytochemical screening and antidepressant activity of ethanolic extract of the neptunia natans leaf extract in Swiss albino mice. The Phytochemicals was extracted using ethanol as a...

Effect of Ruta graveolens on pentylenetetrazol and electrically induced convulsions in albino mice

Ruta graveolens is a plant commonly found in north Africa and south Europe. It is reported that Ruta graveolens is used traditionally for children epilepsy. The chemically induced convulsion by pentylenetetrazol (PTZ) i...

Formulation and Characterization of Aspirin loaded modified release Microsponges by statistical design

Aspirin loaded microsponge can be used to deliver particles to the intestinal region for reducing the side effects and give sustained release effect. Quasi emulsion solvent diffusion method was used to prepare Aspirin lo...

Screening of antioxidant action of hesperidin in high cholesterol diet model in Wistar albino rats

Background Oxidative stress causes of various diseases in human. The present study aimed to evaluate the antioxidant effect of hesperidin in high cholesterol rats. Aim To evaluate the antioxidant action of hesperidin...

Download PDF file
  • EP ID EP655358
  • DOI -
  • Views 53
  • Downloads 0

How To Cite

Dr Sushma H K (2019). Comparative study on efficacy and safety of Rosuvastatin v/s Atorvastatin in patients with metabolic syndrome- a prospective observational study. International Journal of Research in Pharmacology & Pharmacotherapeutics (IJRPP), 8(3), 326-334. https://europub.co.uk/articles/-A-655358